Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Solar Fund Regulatory News (FSFL)

Share Price Information for Foresight Solar Fund (FSFL)

Share Price is delayed by 15 minutes
Get Live Data
70.40    0.10 (0.14%)
Bid:
69.50
Ask:
71.80
Spread: 2.30 (3.309%)
Market Cap: £384.18m
FSFL Live PriceLast checked at - London Stock Exchange

Intraday Foresight Solar Fund Share Chart

Notification Amendment-Director/PDMR Shareholding

12 May 2023 12:00

RNS Number : 2671Z
Foresight Solar Fund Limited
12 May 2023
 

12 May 2023

Foresight Solar Fund Limited

(the "Company")

PDMR Notification Amendment

The Company announced earlier today that Peter Dicks, a Non-Executive Director of the Company and a person discharging managerial responsibilities in the Company ("PDMR"), has, on 11 May 2023, acquired 100,000 ordinary shares at a price of 110.84p per share.

In total, Peter Dicks will be interested in 283,105 Ordinary Shares, representing approximately 0.0464% per cent of the Company's issued Ordinary Share capital.

PDMR Notification Form:

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further details:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

Peter Dicks

2.

Reason for the Notification

a)

Position/status

PDMRNon-Executive Director

b)

Initial notification/amendment

Amendment notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Foresight Solar Fund Limited

b)

LEI

213800VO4O83JVSSOX33

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

JE00BD3QJR55

b)

Nature of the Transaction

Acquisition of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

110.84 pence

100,000

d)

Aggregated informationAggregated volume Price

100,000 ordinary shares in aggregate£110,840.00

e)

Date of the transaction

11 May 2023

f)

Place of the transaction

London Stock Exchange

ENDS

Foresight GroupMatheus Fierro MFierro@Foresightgroup.eu  

+44 (0)20 3667 8147

JTC (Jersey) Limited Christopher Gibbons Foresightsolar@jtcgroup.com

+44 (0)203 846 9774

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAESAFSNDEFA
Date   Source Headline
2nd Sep 20203:00 pmRNSDirector/PDMR Shareholding
26th Aug 202012:07 pmRNSAdditional listing pursuant to Scrip Alternative
25th Aug 20203:41 pmRNSAppointment of Non-Executive Director
21st Aug 20201:46 pmRNSHolding(s) in Company
6th Aug 20202:39 pmRNSScrip Share Price
4th Aug 20207:00 amRNSNotice of Results
22nd Jul 20207:00 amRNSDeclaration of Dividend
16th Jul 20204:24 pmRNSResult of 2020 Annual General Meeting
8th Jul 20203:13 pmRNSDirector Shareholding
23rd Jun 20207:00 amRNSNotice of 2020 Annual General Meeting
1st Jun 202011:04 amRNSTotal Voting Rights
26th May 20204:04 pmRNSAdditional listing pursuant to Scrip Alternative
11th May 20202:33 pmRNSScrip Share Price
4th May 20207:00 amRNSQ1 2020 Net Asset Value and Operational Update
27th Mar 20207:00 amRNSCOVID-19 Update
26th Mar 20207:00 amRNSAppointment of Corporate Broker
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSAnnual Results to 31 December 2019
27th Feb 20207:00 amRNSAdditional listing pursuant to Scrip Alternative
26th Feb 20207:00 amRNSRestructuring of Investment Management Arrangement
19th Feb 20207:00 amRNSQ4 2019 Net Asset Value
6th Feb 20201:59 pmRNSScrip Share Price
3rd Feb 20207:00 amRNSNotice of Results
23rd Jan 202012:08 pmRNSCORRECTION: Dividend Declaration
22nd Jan 20204:21 pmRNSDividend Declaration
29th Nov 20196:09 pmRNSTotal Voting Rights
28th Nov 20199:36 amRNSOFGEM 'Targeted Charging Review' Update
28th Nov 20199:33 amRNSAdditional Scrip Listing and Total Voting Rights
14th Nov 20192:27 pmRNSDirector Declaration
11th Nov 20197:00 amRNSQ3 2019 Net Asset Value
31st Oct 20192:46 pmRNSScrip Share Price and Total Voting Rights
17th Oct 20195:00 pmRNSHolding(s) in Company
10th Oct 20197:00 amRNSResult of Placing and Total Voting Rights
1st Oct 20197:00 amRNSProposed Placing of Ordinary Shares and NAV
25th Sep 20199:25 amRNSHolding(s) in Company
3rd Sep 20194:10 pmRNSHolding(s) in Company
29th Aug 201911:51 amRNSAdditional Listing - Scrip Alternative and TVR
22nd Aug 20197:00 amRNSInterim Results and Dividend Announcement
5th Aug 20197:00 amRNSCompletion of £245 million debt refinancing
1st Aug 20191:59 pmRNSScrip Share Price
30th Jul 20192:20 pmRNSNotice of Interim Results
11th Jul 20195:02 pmRNSDividend Declaration and Scrip Alternative Offer
11th Jul 20193:32 pmRNSDividend Declaration and Scrip Alternative Offer
26th Jun 201910:29 amRNSAmended: Result of AGM
26th Jun 20199:21 amRNSResult of AGM
10th Jun 20197:00 amRNSNotice of AGM
5th Jun 20197:07 amRNSForesight Group acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.